ChiHsien Chan - Adimmune Corp CEO Chairman
4142 Stock | TWD 21.25 0.40 1.85% |
Insider
ChiHsien Chan is CEO Chairman of Adimmune Corp
Phone | 886 4 2538 1220 |
Web | https://www.adimmune.com.tw |
Adimmune Corp Management Efficiency
The company has return on total asset (ROA) of 0.0139 % which means that it generated a profit of $0.0139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0655 %, meaning that it generated $0.0655 on every $100 dollars invested by stockholders. Adimmune Corp's management efficiency ratios could be used to measure how well Adimmune Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Chun Wu | Apex Biotechnology Corp | N/A | |
David Sun | Cathay Financial Holding | 59 | |
JuiHung Hung | Cathay Financial Holding | N/A | |
TangChieh Wu | Cathay Financial Holding | N/A | |
ShuFen Cheng | Cathay Financial Holding | N/A | |
Ben Shen | Apex Biotechnology Corp | N/A | |
ChinTzu Lin | Ruentex Development Co | N/A | |
Andrew Bao | Leader Electronics | N/A | |
Thomas Shen | Apex Biotechnology Corp | N/A | |
Shane Sun | Cathay Financial Holding | N/A | |
ChienWen Kuo | Advanced Ceramic X | N/A | |
TiaoKuei Huang | Cathay Financial Holding | N/A | |
Xiang Xia | WiseChip Semiconductor | N/A | |
TsungHsien Tsai | Cathay Financial Holding | N/A | |
ChiaoLi Pan | Giant Manufacturing Co | N/A | |
ChingYao Peng | Advanced Ceramic X | N/A | |
ShengChang Chang | Giant Manufacturing Co | N/A | |
Jin Zheng | Giant Manufacturing Co | N/A | |
James Chu | Apex Biotechnology Corp | N/A | |
Jun Shi | WiseChip Semiconductor | N/A | |
ShuYing Wu | Cathay Financial Holding | N/A |
Management Performance
Return On Equity | 0.0655 | |||
Return On Asset | 0.0139 |
Adimmune Corp Leadership Team
Elected by the shareholders, the Adimmune Corp's board of directors comprises two types of representatives: Adimmune Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adimmune. The board's role is to monitor Adimmune Corp's management team and ensure that shareholders' interests are well served. Adimmune Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adimmune Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fei Pan, Chief Legal Affairs Officer | ||
ChinChuan Chang, COO RD | ||
LiYa Tang, Director Center | ||
ChihHsiang Leng, Head Division | ||
ChungCheng Liu, GM Pres | ||
YinTeng Chang, Chief Officer | ||
MBA MD, Chief Officer | ||
ChiHsien Chan, CEO Chairman |
Adimmune Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Adimmune Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0655 | |||
Return On Asset | 0.0139 | |||
Profit Margin | 0.21 % | |||
Operating Margin | 0.08 % | |||
Current Valuation | 15.44 B | |||
Shares Outstanding | 421.51 M | |||
Shares Owned By Insiders | 16.90 % | |||
Shares Owned By Institutions | 15.86 % | |||
Price To Earning | (7.22) X | |||
Price To Book | 2.47 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Adimmune Stock Analysis
When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.